Tissue-Level Drug Effect Estimation Using Cell-Tissue Similarity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods struggle to accurately estimate drug effects in vivo tissues using cell-level information from laboratory-cultured cell lines due to differences in cellular interactions and growth environments.
Innovation Solution
A method and device that calculate a similarity between target tissues and cells based on omics data, such as gene expression data, to synthesize cell-level information and estimate tissue-level drug effects, using techniques like vector similarity and classification models.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cell-level drug effect information from in vitro cell lines is used directly to estimate tissue-level drug effects, then the estimation process is simple and quick, but the accuracy of the estimation is poor due to differences between in vitro and in vivo environments
Solution Approach 1:
The patent introduces an intermediary computational framework that bridges in vitro cell-level data and in vivo tissue-level predictions. This framework includes: (1) constructing a cell-tissue similarity metric based on gene expression profiles, (2) developing a weighting system that assigns importance to different cell lines based on their similarity to target tissues, and (3) creating an integration model that combines cell-level drug effects into tissue-level predictions. This intermediary system resolves the contradiction by adding structured complexity that systematically translates between different biological contexts, thereby improving accuracy without arbitrary complexity
Solution Approach 2:
The patent transforms the estimation approach by changing key parameters: (1) introducing similarity scores as a new parameter to quantify the relationship between cell lines and tissues, (2) using gene expression levels as dynamic parameters to adjust weighting of different cell lines, and (3) converting static cell-level IC50 values into dynamic tissue-level predictions through mathematical transformation. These parameter changes enable accurate translation from in vitro to in vivo contexts by accounting for biological variability
2Reliability
If cell-level information from laboratory-cultured cell lines is used, then the data acquisition is easy and cost-effective, but the reliability of tissue-level estimation is reduced due to differences in cellular interactions and growth environments
Solution Approach 1:
The patent applies preliminary action by pre-characterizing cell lines with comprehensive gene expression profiles and pre-calculating similarity metrics before actual drug effect estimation. This preparatory work includes: (1) establishing reference gene expression databases for multiple cell lines, (2) pre-computing similarity scores between cell lines and target tissues, and (3) creating a standardized weighting system in advance. When drug effects need to be estimated, this pre-established framework allows rapid and reliable predictions without repeating complex analytical work, thus maintaining ease of use while improving reliability
Solution Approach 2:
The patent implements feedback mechanisms where the similarity scores and weighting systems are continuously refined based on validation against known tissue-level drug effects. The system learns from discrepancies between predicted and observed outcomes, adjusting the weighting of different cell lines and refining similarity metrics. This feedback loop ensures that the easy-to-acquire cell-level data is systematically improved to match actual tissue responses, enhancing reliability while maintaining the advantage of using accessible in vitro data
Data Source
AI summary
Provided are a method for estimating tissue-level information from cell-level information, and a device therefor. An estimation method according to several embodiments of the present disclosure may comprise the steps of: calculating the similarity between target tissue and a plurality of cells on the basis of first omics data on the target tissue and the second omics data on the plurality of cells associated with the target tissue, and estimating information about the target tissue by synthesizing the information about the plurality of cells on the basis of the calculated similarity. Here, the information about the plurality of cells is differentially synthesized on the basis of the tissue-cell similarity so that the information about the target tissue can be accurately estimated.